About: Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
Creator	Raoult, Didier Colson, Philippe Gautret, Philippe Brouqui, Philippe Parola, Philippe Ailhaud, Lucie Aubry, Camille Baron, Sophie Doudier, Barbara Dudouet, Pierre Flores, Rémi Gouriet, Frédérique Salomon, Jérôme Lagier, Jean Scola, Bernard Dupont, Hervé
topic	covid:8517d45c79ceb3302e56904bf028a7ec6140db41#this
Source	Elsevier; Medline; PMC
abstract	BACKGROUND: An ongoing epidemic of respiratory diseases caused by a novel coronavirus (COVID 2019, SARS-CoV2) started in Wuhan, Hubei, in China at the end of December 2019. The French government decided to repatriate the 337 French nationals living in Wuhan and place them in quarantine in their home country. We decided to test them all for SARS-Cov2 twice in order to reduce anxiety among the population and decision-makers. METHODS: We investigated the presence of SARS-CoV-19 in asymptomatic carriers by testing all repatriated patients within the first 24 h of their arrival in France and at day 5. Viral RNA was extracted from pooled nasal and oropharyngeal swab fluids or sputum in the absence of nasal/oropharyngeal swabs. Detection of SARS-CoV-2 RNA was then carried out using several real-time reverse transcription (RT)-PCR assays. RESULTS: We tested 337 passengers at day 0 and day 5. All the tests for SARS-CoV2 were negative. By optimising the sampling process, sending samples sequentially and reducing the time-scale for biological analysis, we were able to test the samples within 5 h (including sampling, shipment and biological tests). CONCLUSION: Optimising our procedures reduces anxiety and reassures the population and decision makers.
has issue date	2020-03-14(xsd:dateTime)
bibo:doi	10.1016/j.tmaid.2020.101624
bibo:pmid	32179125
has license	no-cc
sha1sum (hex)	8517d45c79ceb3302e56904bf028a7ec6140db41
schema:url	https://doi.org/10.1016/j.tmaid.2020.101624
resource representing a document's title	Testing the repatriated for SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine?
has PubMed Central identifier	PMC7102645
has PubMed identifier	32179125
schema:publication	Travel Med Infect Dis
resource representing a document's body	covid:8517d45c79ceb3302e56904bf028a7ec6140db41#body_text
is http://vocab.deri.ie/void#inDataset of	https://covidontheweb.inria.fr:4443/about/id/http/ns.inria.fr/covid19/8517d45c79ceb3302e56904bf028a7ec6140db41
is schema:about of	named entity 'TRADITIONAL' named entity 'samples' named entity 'nasal' named entity 'carried' named entity 'SARS-CoV-2' named entity 'traditional' named entity 'SAMPLES' named entity 'SARS-COV' named entity 'THEIR' named entity 'RESPIRATORY DISEASES' named entity 'REDUCING' named entity 'PRESENCE OF' named entity 'SPUTUM' named entity 'PCR' named entity 'QUARANTINE' named entity 'TESTING' named entity 'EXTRACTED' named entity 'VIRAL RNA' named entity 'TESTS' named entity 'BIOLOGICAL ANALYSIS' named entity 'INVESTIGATED' named entity 'REAL-TIME' named entity 'CARRIED' named entity 'TO REDUCE' named entity 'STARTED' named entity 'SHIPMENT' named entity 'DECEMBER' named entity 'SENDING' named entity 'GOVERNMENT' named entity 'BIOLOGICAL' named entity 'SARS' named entity 'TWICE' named entity 'POOLED' named entity 'EPIDEMIC' named entity 'USING' named entity 'ANXIETY' named entity 'TO TEST' named entity 'NEGATIVE' named entity '2019' named entity 'LIVING' named entity 'BACKGROUND' named entity 'HOME' named entity 'PLACE' named entity 'ORDER' named entity 'SARS' named entity 'DAY' named entity 'PROCESS' named entity 'ABSENCE OF' named entity 'ASYMPTOMATIC CARRIERS' named entity 'TIME' named entity 'PASSENGERS' named entity 'SWABS' named entity 'POPULATION' named entity 'TESTING' named entity 'BASED' named entity 'SARS-COV-2 RNA' named entity 'AT THE END' named entity 'FRANCE' named entity 'COUNTRY' named entity 'LABORATORY' named entity 'REPLACE' named entity 'QUARANTINE' named entity 'OROPHARYNGEAL SWAB' named entity 'SCALE'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software